{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:12:13Z","timestamp":1790165533627,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","award":["R01 AR56679"],"award-info":[{"award-number":["R01 AR56679"]}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","award":["R01 AG068449"],"award-info":[{"award-number":["R01 AG068449"]}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","award":["P20 GM125503"],"award-info":[{"award-number":["P20 GM125503"]}]},{"name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","award":["R01 CA258673"],"award-info":[{"award-number":["R01 CA258673"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-01717-5","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:02:49Z","timestamp":1747616569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The adverse effects of chemotherapy on bone mass are not prevented by senolytics"],"prefix":"10.1038","volume":"15","author":[{"given":"Md Mohsin","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon B.","family":"Gatrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Resende-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anti\u00f1o R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"1717_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72, 409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"1717_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae135","author":"E Tonorezos","year":"2024","unstructured":"Tonorezos, E. et al. Prevalence of cancer survivors in the United States. J. Natl. Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djae135 (2024).","journal-title":"J. Natl. Cancer Inst."},{"key":"1717_CR3","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1002\/cncr.33112","volume":"126","author":"AB Smitherman","year":"2020","unstructured":"Smitherman, A. B. et al. Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16(INK4a) and frailty. Cancer 126, 4975\u20134983. https:\/\/doi.org\/10.1002\/cncr.33112 (2020).","journal-title":"Cancer"},{"key":"1717_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13058-021-01388-w","volume":"23","author":"N Gilmore","year":"2021","unstructured":"Gilmore, N. et al. The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy. Breast Cancer Res. 23, 19. https:\/\/doi.org\/10.1186\/s13058-021-01388-w (2021).","journal-title":"Breast Cancer Res."},{"key":"1717_CR5","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/cncr.34818","volume":"129","author":"KE Rentscher","year":"2023","unstructured":"Rentscher, K. E. et al. Epigenetic aging in older breast cancer survivors and noncancer controls: Preliminary findings from the Thinking and Living with Cancer Study. Cancer 129, 2741\u20132753. https:\/\/doi.org\/10.1002\/cncr.34818 (2023).","journal-title":"Cancer"},{"key":"1717_CR6","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.1002\/cam4.5908","volume":"12","author":"SC Gehle","year":"2023","unstructured":"Gehle, S. C. et al. Accelerated epigenetic aging and myopenia in young adult cancer survivors. Cancer Med. 12, 12149\u201312160. https:\/\/doi.org\/10.1002\/cam4.5908 (2023).","journal-title":"Cancer Med."},{"key":"1717_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jgo.2021.07.011","volume":"13","author":"TA Ahles","year":"2022","unstructured":"Ahles, T. A. et al. Relationship between cognitive functioning and frailty in older breast cancer survivors. J. Geriatr. Oncol. 13, 27\u201332. https:\/\/doi.org\/10.1016\/j.jgo.2021.07.011 (2022).","journal-title":"J. Geriatr. Oncol."},{"key":"1717_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoncol.2022.5153","volume":"9","author":"E Rees-Punia","year":"2023","unstructured":"Rees-Punia, E. et al. Fracture risk among older cancer survivors compared with older adults without a history of cancer. JAMA Oncol. 9, 79\u201387. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5153 (2023).","journal-title":"JAMA Oncol."},{"key":"1717_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archinte.165.5.552","volume":"165","author":"Z Chen","year":"2005","unstructured":"Chen, Z. et al. Fracture risk among breast cancer survivors: Results from the Women\u2019s Health Initiative Observational Study. Arch. Intern. Med. 165, 552\u2013558. https:\/\/doi.org\/10.1001\/archinte.165.5.552 (2005).","journal-title":"Arch. Intern. Med."},{"key":"1717_CR10","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","volume":"45","author":"P Hadji","year":"2009","unstructured":"Hadji, P., Ziller, M., Maskow, C., Albert, U. & Kalder, M. The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur. J. Cancer 45, 3205\u20133212. https:\/\/doi.org\/10.1016\/j.ejca.2009.09.026 (2009).","journal-title":"Eur. J. Cancer"},{"key":"1717_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2014.12.028","volume":"402","author":"DR Oostra","year":"2015","unstructured":"Oostra, D. R. et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Mol. Cell Endocrinol. 402, 51\u201356. https:\/\/doi.org\/10.1016\/j.mce.2014.12.028 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"1717_CR12","doi-asserted-by":"publisher","unstructured":"Go, J. et al. Risk of osteoporosis and fracture in long-term breast cancer survivors. Korean J. Clin. Oncol. 16, 39\u201345. https:\/\/doi.org\/10.14216\/kjco.20007 (2020).","DOI":"10.14216\/kjco.20007"},{"key":"1717_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","volume":"24","author":"L Vehmanen","year":"2006","unstructured":"Vehmanen, L., Elomaa, I., Blomqvist, C. & Saarto, T. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J. Clin. Oncol. 24, 675\u2013680. https:\/\/doi.org\/10.1200\/JCO.2005.02.3515 (2006).","journal-title":"J. Clin. Oncol."},{"key":"1717_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1210\/edrv.21.2.0395","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas, S. C. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115\u2013137. https:\/\/doi.org\/10.1210\/edrv.21.2.0395 (2000).","journal-title":"Endocr. Rev."},{"key":"1717_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078043","volume":"8","author":"T Rana","year":"2013","unstructured":"Rana, T., Chakrabarti, A., Freeman, M. & Biswas, S. Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFbeta. PLoS ONE 8, e78043. https:\/\/doi.org\/10.1371\/journal.pone.0078043 (2013).","journal-title":"PLoS ONE"},{"key":"1717_CR16","doi-asserted-by":"publisher","unstructured":"Park, H. J., Yoon, S. Y., Park, J. N., Suh, J. H. & Choi, H. S. Doxorubicin induces bone loss by increasing autophagy through a mitochondrial ROS\/TRPML1\/TFEB axis in osteoclasts. Antioxidants (Basel). 11. https:\/\/doi.org\/10.3390\/antiox11081476 (2022).","DOI":"10.3390\/antiox11081476"},{"key":"1717_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1158\/0008-5472.CAN-19-2348","volume":"80","author":"Z Yao","year":"2020","unstructured":"Yao, Z. et al. Therapy-induced senescence drives bone loss. Cancer Res. 80, 1171\u20131182. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-2348 (2020).","journal-title":"Cancer Res."},{"key":"1717_CR18","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00198-017-4032-1","volume":"28","author":"AJ Koh","year":"2017","unstructured":"Koh, A. J., Sinder, B. P., Entezami, P., Nilsson, L. & McCauley, L. K. The skeletal impact of the chemotherapeutic agent etoposide. Osteoporos Int. 28, 2321\u20132333. https:\/\/doi.org\/10.1007\/s00198-017-4032-1 (2017).","journal-title":"Osteoporos Int."},{"key":"1717_CR19","doi-asserted-by":"publisher","first-page":"98163","DOI":"10.18632\/oncotarget.21000","volume":"8","author":"D Zhao","year":"2017","unstructured":"Zhao, D. et al. Cyclophosphamide causes osteoporosis in C57BL\/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis. Oncotarget 8, 98163\u201398183. https:\/\/doi.org\/10.18632\/oncotarget.21000 (2017).","journal-title":"Oncotarget"},{"key":"1717_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/jbmr.2415","volume":"30","author":"JM Quach","year":"2015","unstructured":"Quach, J. M. et al. Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss. J. Bone Miner. Res. 30, 886\u2013897. https:\/\/doi.org\/10.1002\/jbmr.2415 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"1717_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1172\/JCI111096","volume":"72","author":"AM Parfitt","year":"1983","unstructured":"Parfitt, A. M. et al. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J. Clin. Investig. 72, 1396\u20131409. https:\/\/doi.org\/10.1172\/JCI111096 (1983).","journal-title":"J. Clin. Investig."},{"key":"1717_CR23","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1210\/jc.2010-0856","volume":"95","author":"S Khosla","year":"2010","unstructured":"Khosla, S. Update on estrogens and the skeleton. J. Clin. Endocrinol. Metab. 95, 3569\u20133577. https:\/\/doi.org\/10.1210\/jc.2010-0856 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1717_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27397","volume":"65","author":"RH Johnson","year":"2018","unstructured":"Johnson, R. H., Anders, C. K., Litton, J. K., Ruddy, K. J. & Bleyer, A. Breast cancer in adolescents and young adults. Pediatr. Blood Cancer 65, e27397. https:\/\/doi.org\/10.1002\/pbc.27397 (2018).","journal-title":"Pediatr. Blood Cancer"},{"key":"1717_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13058-018-1061-4","volume":"20","author":"C Ramin","year":"2018","unstructured":"Ramin, C. et al. Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study. Breast Cancer Res. 20, 134. https:\/\/doi.org\/10.1186\/s13058-018-1061-4 (2018).","journal-title":"Breast Cancer Res."},{"key":"1717_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/bjc.1990.58","volume":"61","author":"PF Bruning","year":"1990","unstructured":"Bruning, P. F. et al. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br. J. Cancer 61, 308\u2013310. https:\/\/doi.org\/10.1038\/bjc.1990.58 (1990).","journal-title":"Br. J. Cancer"},{"key":"1717_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1006\/excr.2000.4838","volume":"256","author":"SH Kaufmann","year":"2000","unstructured":"Kaufmann, S. H. & Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42\u201349. https:\/\/doi.org\/10.1006\/excr.2000.4838 (2000).","journal-title":"Exp. Cell Res."},{"key":"1717_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mehy.2006.01.045","volume":"67","author":"RE Maccormick","year":"2006","unstructured":"Maccormick, R. E. Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?. Med. Hypotheses 67, 212\u2013215. https:\/\/doi.org\/10.1016\/j.mehy.2006.01.045 (2006).","journal-title":"Med. Hypotheses"},{"key":"1717_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","volume":"7","author":"M Demaria","year":"2017","unstructured":"Demaria, M. et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 7, 165\u2013176. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0241 (2017).","journal-title":"Cancer Discov."},{"key":"1717_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: Defining a path forward. Cell 179, 813\u2013827. https:\/\/doi.org\/10.1016\/j.cell.2019.10.005 (2019).","journal-title":"Cell"},{"key":"1717_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi, J. & di d\u2019Adda Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729\u2013740. https:\/\/doi.org\/10.1038\/nrm2233 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1717_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169512","author":"DA Englund","year":"2024","unstructured":"Englund, D. A. et al. Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.169512 (2024).","journal-title":"JCI Insight"},{"key":"1717_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108503","volume":"27","author":"DW Perkins","year":"2024","unstructured":"Perkins, D. W. et al. Therapy-induced normal tissue damage promotes breast cancer metastasis. iScience 27, 108503. https:\/\/doi.org\/10.1016\/j.isci.2023.108503 (2024).","journal-title":"iScience"},{"key":"1717_CR34","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s11357-023-00728-2","volume":"45","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Increased cellular senescence in doxorubicin-induced murine ovarian injury: Effect of senolytics. Geroscience 45, 1775\u20131790. https:\/\/doi.org\/10.1007\/s11357-023-00728-2 (2023).","journal-title":"Geroscience"},{"key":"1717_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106356","volume":"183","author":"A Lerida-Viso","year":"2022","unstructured":"Lerida-Viso, A. et al. Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice. Pharmacol. Res. 183, 106356. https:\/\/doi.org\/10.1016\/j.phrs.2022.106356 (2022).","journal-title":"Pharmacol. Res."},{"key":"1717_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14037","volume":"23","author":"V Budamagunta","year":"2024","unstructured":"Budamagunta, V. et al. Senolytic treatment alleviates doxorubicin-induced chemobrain. Aging Cell 23, e14037. https:\/\/doi.org\/10.1111\/acel.14037 (2024).","journal-title":"Aging Cell"},{"key":"1717_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166643","author":"S Li","year":"2023","unstructured":"Li, S. et al. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.166643 (2023).","journal-title":"JCI Insight."},{"key":"1717_CR38","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","volume":"28","author":"S Chaib","year":"2022","unstructured":"Chaib, S., Tchkonia, T. & Kirkland, J. L. Cellular senescence and senolytics: The path to the clinic. Nat. Med. 28, 1556\u20131568. https:\/\/doi.org\/10.1038\/s41591-022-01923-y (2022).","journal-title":"Nat. Med."},{"key":"1717_CR39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J. & Robbins, P. D. Targeting cellular senescence with senotherapeutics: Senolytics and senomorphics. FEBS J. 290, 1362\u20131383. https:\/\/doi.org\/10.1111\/febs.16350 (2023).","journal-title":"FEBS J."},{"key":"1717_CR40","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.18632\/aging.101100","volume":"8","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Aging (Albany NY). 8, 2915\u20132926. https:\/\/doi.org\/10.18632\/aging.101100 (2016).","journal-title":"Aging (Albany NY)."},{"key":"1717_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079. https:\/\/doi.org\/10.1038\/nm.4385 (2017).","journal-title":"Nat. Med."},{"key":"1717_CR42","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1038\/s41467-021-25453-2","volume":"12","author":"EJ Novais","year":"2021","unstructured":"Novais, E. J. et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 12, 5213. https:\/\/doi.org\/10.1038\/s41467-021-25453-2 (2021).","journal-title":"Nat. Commun."},{"key":"1717_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13832","volume":"22","author":"C Ahire","year":"2023","unstructured":"Ahire, C. et al. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. Aging Cell 22, e13832. https:\/\/doi.org\/10.1111\/acel.13832 (2023).","journal-title":"Aging Cell"},{"key":"1717_CR44","doi-asserted-by":"publisher","first-page":"9144644","DOI":"10.1155\/2022\/9144644","volume":"2022","author":"D Du","year":"2022","unstructured":"Du, D. et al. Senotherapy protects against cisplatin-induced ovarian injury by removing senescent cells and alleviating DNA damage. Oxid. Med. Cell Longev. 2022, 9144644. https:\/\/doi.org\/10.1155\/2022\/9144644 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1717_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2217\/17455057.2.4.527","volume":"2","author":"M Martin","year":"2006","unstructured":"Martin, M. Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): An effective adjuvant treatment for operable breast cancer. Womens Health (Lond.) 2, 527\u2013537. https:\/\/doi.org\/10.2217\/17455057.2.4.527 (2006).","journal-title":"Womens Health (Lond.)"},{"key":"1717_CR46","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1200\/JCO.2006.06.5391","volume":"24","author":"SE Jones","year":"2006","unstructured":"Jones, S. E. et al. Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J. Clin. Oncol. 24, 5381\u20135387. https:\/\/doi.org\/10.1200\/JCO.2006.06.5391 (2006).","journal-title":"J. Clin. Oncol."},{"key":"1717_CR47","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/toxsci\/kfx267","volume":"162","author":"TJ Flanigan","year":"2018","unstructured":"Flanigan, T. J., Anderson, J. E., Elayan, I., Allen, A. R. & Ferguson, S. A. Effects of cyclophosphamide and\/or doxorubicin in a murine model of postchemotherapy cognitive impairment. Toxicol. Sci. 162, 462\u2013474. https:\/\/doi.org\/10.1093\/toxsci\/kfx267 (2018).","journal-title":"Toxicol. Sci."},{"key":"1717_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042008","author":"F Ntagwabira","year":"2022","unstructured":"Ntagwabira, F. et al. Piperlongumine as a neuro-protectant in chemotherapy induced cognitive impairment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23042008 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1717_CR49","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1038\/ncomms4773","volume":"5","author":"SM Bartell","year":"2014","unstructured":"Bartell, S. M. et al. FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat. Commun. 5, 3773. https:\/\/doi.org\/10.1038\/ncomms4773 (2014).","journal-title":"Nat. Commun."},{"key":"1717_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jbmr.2007","volume":"29","author":"RL Jilka","year":"2014","unstructured":"Jilka, R. L. et al. Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. J. Bone Miner. Res. 29, 103\u2013117. https:\/\/doi.org\/10.1002\/jbmr.2007 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"1717_CR51","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1038\/s41467-023-39392-7","volume":"14","author":"A Warren","year":"2023","unstructured":"Warren, A. et al. The NAD salvage pathway in mesenchymal cells is indispensable for skeletal development in mice. Nat. Commun. 14, 3616. https:\/\/doi.org\/10.1038\/s41467-023-39392-7 (2023).","journal-title":"Nat. Commun."},{"key":"1717_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2\u201317. https:\/\/doi.org\/10.1002\/jbmr.1805 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"1717_CR53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"1717_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","volume":"567","author":"V Amrhein","year":"2019","unstructured":"Amrhein, V., Greenland, S. & McShane, B. Scientists rise up against statistical significance. Nature 567, 305\u2013307. https:\/\/doi.org\/10.1038\/d41586-019-00857-9 (2019).","journal-title":"Nature"},{"key":"1717_CR55","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fendo.2019.00809","volume":"10","author":"AL Essex","year":"2019","unstructured":"Essex, A. L. et al. Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice. Front. Endocrinol. (Lausanne) 10, 809. https:\/\/doi.org\/10.3389\/fendo.2019.00809 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"1717_CR56","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827. https:\/\/doi.org\/10.1038\/s41467-022-32552-1 (2022).","journal-title":"Nat. Commun."},{"key":"1717_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11914-016-0297-0","volume":"14","author":"RL Jilka","year":"2016","unstructured":"Jilka, R. L. & O\u2019Brien, C. A. The role of osteocytes in age-related bone loss. Curr. Osteoporos. Rep. 14, 16\u201325. https:\/\/doi.org\/10.1007\/s11914-016-0297-0 (2016).","journal-title":"Curr. Osteoporos. Rep."},{"key":"1717_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107158","volume":"300","author":"I Nookaew","year":"2024","unstructured":"Nookaew, I. et al. Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone. J. Biol. Chem. 300, 107158. https:\/\/doi.org\/10.1016\/j.jbc.2024.107158 (2024).","journal-title":"J. Biol. Chem."},{"key":"1717_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54695","author":"L Zhong","year":"2020","unstructured":"Zhong, L. et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment. Elife https:\/\/doi.org\/10.7554\/eLife.54695 (2020).","journal-title":"Elife"},{"key":"1717_CR60","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jbmr.2892","volume":"31","author":"JN Farr","year":"2016","unstructured":"Farr, J. N. et al. Identification of senescent cells in the bone microenvironment. J. Bone Miner. Res. 31, 1920\u20131929. https:\/\/doi.org\/10.1002\/jbmr.2892 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"1717_CR61","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246\u20131256. https:\/\/doi.org\/10.1038\/s41591-018-0092-9 (2018).","journal-title":"Nat. Med."},{"key":"1717_CR62","doi-asserted-by":"publisher","first-page":"27285","DOI":"10.1074\/jbc.M702810200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida, M. et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J. Biol. Chem. 282, 27285\u201327297. https:\/\/doi.org\/10.1074\/jbc.M702810200 (2007).","journal-title":"J. Biol. Chem."},{"key":"1717_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115438","volume":"137","author":"D Harris","year":"2020","unstructured":"Harris, D., Garrett, K., Uppuganti, S., Creecy, A. & Nyman, J. S. The BALB\/c mouse as a preclinical model of the age-related deterioration in the lumbar vertebra. Bone 137, 115438. https:\/\/doi.org\/10.1016\/j.bone.2020.115438 (2020).","journal-title":"Bone"},{"key":"1717_CR64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00223-010-9359-y","volume":"86","author":"MD Willinghamm","year":"2010","unstructured":"Willinghamm, M. D. et al. Age-related changes in bone structure and strength in female and male BALB\/c mice. Calcif. Tissue Int. 86, 470\u2013483. https:\/\/doi.org\/10.1007\/s00223-010-9359-y (2010).","journal-title":"Calcif. Tissue Int."},{"key":"1717_CR65","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3892\/ijmm.2018.3782","volume":"42","author":"J Go","year":"2018","unstructured":"Go, J. et al. Piperlongumine decreases cognitive impairment and improves hippocampal function in aged mice. Int. J. Mol. Med. 42, 1875\u20131884. https:\/\/doi.org\/10.3892\/ijmm.2018.3782 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"1717_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0092-8674(02)00734-1","volume":"109","author":"CA Schmitt","year":"2002","unstructured":"Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335\u2013346. https:\/\/doi.org\/10.1016\/s0092-8674(02)00734-1 (2002).","journal-title":"Cell"},{"key":"1717_CR67","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1038\/sj.onc.1203078","volume":"18","author":"BD Chang","year":"1999","unstructured":"Chang, B. D. et al. Role of p53 and p21waf1\/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18, 4808\u20134818. https:\/\/doi.org\/10.1038\/sj.onc.1203078 (1999).","journal-title":"Oncogene"},{"key":"1717_CR68","first-page":"5019","volume":"58","author":"X Wang","year":"1998","unstructured":"Wang, X. et al. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Res. 58, 5019\u20135022 (1998).","journal-title":"Cancer Res."},{"key":"1717_CR69","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/jnci\/djab064","volume":"113","author":"PG Prasanna","year":"2021","unstructured":"Prasanna, P. G. et al. Therapy-induced senescence: Opportunities to improve anticancer therapy. J. Natl. Cancer Inst. 113, 1285\u20131298. https:\/\/doi.org\/10.1093\/jnci\/djab064 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"1717_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","author":"A Marechal","year":"2013","unstructured":"Marechal, A. & Zou, L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a012716 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1717_CR71","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s12276-022-00863-4","volume":"54","author":"Y Abuetabh","year":"2022","unstructured":"Abuetabh, Y. et al. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities. Exp. Mol. Med. 54, 1658\u20131669. https:\/\/doi.org\/10.1038\/s12276-022-00863-4 (2022).","journal-title":"Exp. Mol. Med."},{"key":"1717_CR72","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss, J. L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 9, 338\u2013350. https:\/\/doi.org\/10.1038\/nrc2607 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1717_CR73","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/jbmr.3978","volume":"35","author":"A Chandra","year":"2020","unstructured":"Chandra, A. et al. Targeted reduction of senescent cell burden alleviates focal radiotherapy-related bone loss. J. Bone Miner. Res. 35, 1119\u20131131. https:\/\/doi.org\/10.1002\/jbmr.3978 (2020).","journal-title":"J. Bone Miner. Res."},{"key":"1717_CR74","doi-asserted-by":"crossref","unstructured":"Hain, B. A., Xu, H., Wilcox, J. R., Mutua, D. & Waning, D. L. Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia. JCSM Rapid Commun. 2 (2019).","DOI":"10.1002\/j.2617-1619.2019.tb00011.x"},{"key":"1717_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","volume":"25","author":"CA Mitchell","year":"2023","unstructured":"Mitchell, C. A. et al. Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat. Cell Biol. 25, 30\u201341. https:\/\/doi.org\/10.1038\/s41556-022-01053-0 (2023).","journal-title":"Nat. Cell Biol."},{"key":"1717_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tcb.2022.04.011","volume":"33","author":"RL Cohn","year":"2023","unstructured":"Cohn, R. L., Gasek, N. S., Kuchel, G. A. & Xu, M. The heterogeneity of cellular senescence: insights at the single-cell level. Trends Cell Biol. 33, 9\u201317. https:\/\/doi.org\/10.1016\/j.tcb.2022.04.011 (2023).","journal-title":"Trends Cell Biol."},{"key":"1717_CR77","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/acel.12597","volume":"16","author":"HN Kim","year":"2017","unstructured":"Kim, H. N. et al. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. Aging Cell 16, 693\u2013703. https:\/\/doi.org\/10.1111\/acel.12597 (2017).","journal-title":"Aging Cell"},{"key":"1717_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93771","author":"M Piemontese","year":"2017","unstructured":"Piemontese, M. et al. Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.93771 (2017).","journal-title":"JCI Insight"},{"key":"1717_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138815","author":"HN Kim","year":"2020","unstructured":"Kim, H. N. et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.138815 (2020).","journal-title":"JCI Insight"},{"key":"1717_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12923","volume":"18","author":"HN Kim","year":"2019","unstructured":"Kim, H. N. et al. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice. Aging Cell 18, e12923. https:\/\/doi.org\/10.1111\/acel.12923 (2019).","journal-title":"Aging Cell"},{"key":"1717_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00663-7","author":"S Zumerle","year":"2024","unstructured":"Zumerle, S. et al. Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice. Nat. Aging https:\/\/doi.org\/10.1038\/s43587-024-00663-7 (2024).","journal-title":"Nat. Aging"},{"key":"1717_CR82","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/jnci\/djq364","volume":"102","author":"JA Ewald","year":"2010","unstructured":"Ewald, J. A., Desotelle, J. A., Wilding, G. & Jarrard, D. F. Therapy-induced senescence in cancer. J. Natl. Cancer Inst. 102, 1536\u20131546. https:\/\/doi.org\/10.1093\/jnci\/djq364 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"1717_CR83","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bone.2004.04.027","volume":"35","author":"CJ Xian","year":"2004","unstructured":"Xian, C. J., Howarth, G. S., Cool, J. C. & Foster, B. K. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats. Bone 35, 739\u2013749. https:\/\/doi.org\/10.1016\/j.bone.2004.04.027 (2004).","journal-title":"Bone"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01717-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:02:50Z","timestamp":1747616570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01717-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01717-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17279"}}